New Results
Interleukin-22 mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury
View ORCID ProfileWei Chen, Yilan Shen, Jiajun Fan, Xian Zeng, Xuyao Zhang, Jingyun Luan, Jinghui Zhang, Si Fang, Xiaobin Mei, Dianwen Ju
doi: https://doi.org/10.1101/2020.08.04.237347
Wei Chen
1Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, 201203, P. R. China
2Department of Ophthalmology, Stanford University School of Medicine, Palo Alto CA 94304, USA
Yilan Shen
1Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, 201203, P. R. China
3Department of Nephrology, Changhai Hospital, Second Military Medical University, Shanghai, 200433, P. R. China
Jiajun Fan
1Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, 201203, P. R. China
Xian Zeng
1Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, 201203, P. R. China
Xuyao Zhang
1Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, 201203, P. R. China
4Department of Gastrointestinal Surgery, Changhai Hospital, Second Military Medical University, Shanghai, 200433, P.R.China
Jingyun Luan
1Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, 201203, P. R. China
Jinghui Zhang
1Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, 201203, P. R. China
Si Fang
5Tongcheng Hospital of Traditional Chinese Medicine, Anhui, 231400, P. R. China
Xiaobin Mei
3Department of Nephrology, Changhai Hospital, Second Military Medical University, Shanghai, 200433, P. R. China
Dianwen Ju
1Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, 201203, P. R. China
Article usage
Posted August 05, 2020.
Interleukin-22 mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury
Wei Chen, Yilan Shen, Jiajun Fan, Xian Zeng, Xuyao Zhang, Jingyun Luan, Jinghui Zhang, Si Fang, Xiaobin Mei, Dianwen Ju
bioRxiv 2020.08.04.237347; doi: https://doi.org/10.1101/2020.08.04.237347
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29194)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18305)
- Genetics (12245)
- Genomics (16801)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60962)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)